NatImmune, Nya Hamlet Pharma AB deal

NatImmune acquired Nya for an undisclosed amount of stock. Nya’s lead compound, Hamlet, is a complex of alpha-lactalbumin and oleic acid that has completed a Phase I trial to treat bladder cancer and ...